| Literature DB >> 29226130 |
Wallace Felipe Blohem Pessoa1, Ana Clara Correia Melgaço1, Milena Evangelista de Almeida1, Louise Pereira Ramos1, Rachel Passos Rezende2, Carla Cristina Romano1.
Abstract
Study of the probiotic potential of microorganisms isolated from fermented foods has been increasing, especially studies related to lactobacilli. In intestinal models, lactobacilli have demonstrated beneficial properties, such as anti-inflammatory activity and increased antibody production, but the molecular mechanisms involving probiotic and antagonistic action as well as their effect on human vaginal cells have not yet been fully elucidated. The aim of this study was to evaluate the functional and antagonistic properties of three strains of lactobacilli isolated from cocoa fermentation (Lactobacillus fermentum 5.2, L. plantarum 6.2, and L. plantarum 7.1) against Gardnerella vaginalis. Our results show that the lactobacilli have potential use as probiotics, since they have high hydrophobicity and autoaggregation properties and effectively adhere to vaginal cells. Metabolites secreted into the culture medium and whole cells of the strains under study are capable of interfering with the growth of G. vaginalis to different degrees. The elucidation of the antagonistic mechanisms as well as their effect on human cells may be useful in the development of a product containing such microorganisms or products secreted by them.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29226130 PMCID: PMC5684529 DOI: 10.1155/2017/3264194
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Characterization of surface properties, adhesion to vaginal cells, and antimicrobial properties of lactobacilli isolated from cocoa fermentation.
| Strain | Surface properties | Adhesion to HMVII cells (%) | Antimicrobial properties | ||
|---|---|---|---|---|---|
| Autoaggregation (%) | Hydrophobicity (%) | Coaggregation with | Acidification | ||
|
| 31.18 ± 4.39a | 53.96 ± 2.90a | 35.61 ± 2.98a | 43.15 ± 0.68a | 4.78 |
|
| 33.44 ± 1.53a | 55.52 ± 3.76a | 38.73 ± 2.87a | 44.61 ± 0.17a | 3.81 |
|
| 29.23 ± 1.14a | 71.20 ± 3.03b | 55.75 ± 3.72b | 44.15 ± 0.51a | 3.77 |
Presented values are means of triplicate determinations; ± indicates standard deviations from the mean. Mean values (±standard deviation) within the same column followed by different superscript letters differ significantly (p < 0.05).
Figure 1Scanning electron microscope images of vaginal epithelial cells treated for 2 h with lactobacilli isolated from cocoa fermentation. (a) Untreated HMVII cells (×2,500); (b) HMVII cells treated with L. fermentum 5.2 (×2,500); (c) HMVII cells treated with L. plantarum 6.2 (×2,500); (d) HMVII cells treated with L. plantarum 7.1 (×2,500; details in ×20,000).
Figure 2Evaluation of antimicrobial activity of culture supernatants of lactobacilli isolated from cocoa fermentation against Gardnerella vaginalis. (a) Evaluation by agar diffusion. (b) Determination of minimum inhibitory concentrations. MRS: culture medium; Lf52: L. fermentum 5.2; Lp62: L. plantarum 6.2; and Lp71: L. plantarum 7.1.
Figure 3Effect of lactobacilli isolated from cocoa fermentation on the viability of Gardnerella vaginalis (Gv) as a function of the time of coculture. The pathogen was incubated without (filled shape) or with (empty shape) different lactobacilli (L. fermentum 5.2: Lf52; L. plantarum 6.2: Lp62; or L. plantarum 7.1: Lp71) for 24 hours and CFU mL−1 was determined after 4, 8, and 24 hours of incubation by plating onto appropriate media. Each value shown is the mean ± SD. Statistically significant differences (p < 0.05).
Susceptibility profile of Lactobacillus strains isolated from cocoa fermentation.
| Antimicrobial | Susceptibilitya | ||||
|---|---|---|---|---|---|
| Group | Name | Disc conc. ( |
|
|
|
|
| |||||
| Penicillin | Amoxicillin | 10 | S | S | S |
| Ampicillin | 10 | S | S | S | |
| Penicillin G | 10 | S | MS | MS | |
| Cephalosporins | Cefalotin | 30 | S | S | S |
| Glycopeptides | Vancomycin | 30 | R | R | R |
|
| |||||
| Aminoglycosides | Amikacin | 30 | R | R | R |
| Gentamicin | 10 | R | R | R | |
| Streptomycin | 10 | R | R | R | |
| Tetracyclines | Tetracycline | 30 | S | S | MS |
| Single antibiotics | Chloramphenicol | 30 | S | S | S |
| Macrolides | Erythromycin | 15 | S | S | S |
| Lincosamides | Clindamycin | 2 | S | S | S |
|
| |||||
| Quinolones | Ciprofloxacin | 5 | R | R | R |
| Norfloxacin | 10 | R | R | R | |
|
| |||||
| Single antibiotics | Nitrofurantoin | 300 | S | S | S |
aSusceptibility expressed as sensitive (S), moderately sensitive (MS), or resistant (R) [18].